ADMA Biologics, Inc.

ADMA Biologics, Inc.verified

ADMA

Price:

$8.21

Market Cap:

$1.90B

ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These specialized products are engineered to address immune system disorders and infectious diseases, catering to markets across the United States and internationally. Their current product portfolio includes BIVIGAM and ASCENIV, both intravenous immune globulin (IVIG) treatments prescribed for primary humoral immunodeficiency (PI). Additionally, the company offers Nabi-HB, utilized for immediate treatment following acute exposure to the Hepatitis B virus and other specified exposures. Beyond its existing...[Read more]

Industry

Biotechnology

IPO Date

2013-10-17

Stock Exchange

NASDAQ

Ticker

ADMA

The Enterprise Value as of June 2026 (TTM) for ADMA Biologics, Inc. (ADMA) is 1.97B

According to ADMA Biologics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.97B. This represents a change of -45.44% compared to the average of 3.61B of the last 4 quarters.

ADMA Biologics, Inc. (ADMA) Historical Enterprise Value (quarterly & annually)

How has ADMA Enterprise Value performed in the past?

The mean historical Enterprise Value of ADMA Biologics, Inc. over the last ten years is 1.13B. The current 1.97B Enterprise Value has changed 17.38% with respect to the historical average. Over the past ten years (40 quarters), ADMA's Enterprise Value was at its highest in in the March 2025 quarter at 4.73B. The Enterprise Value was at its lowest in in the June 2017 quarter at 67.85M.

Quarterly (TTM)
Annual

Average

1.13B

Median

262.00M

Minimum

72.57M

Maximum

4.34B

ADMA Biologics, Inc. (ADMA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ADMA Biologics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 260.69%

Maximum Annual Enterprise Value = 4.34B

Minimum Annual Increase = -23.84%

Minimum Annual Enterprise Value = 72.57M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20254.34B9.12%
20243.98B260.69%
20231.10B31.92%
2022835.67M236.10%
2021248.64M18.55%
2020209.73M-23.84%
2019275.37M112.69%
2018129.47M76.49%
201773.36M1.09%
201672.57M-18.75%

ADMA Biologics, Inc. (ADMA) Average Enterprise Value

How has ADMA Enterprise Value performed in the past?

The current Enterprise Value of ADMA Biologics, Inc. (ADMA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

3.14B

5-year avg

2.10B

10-year avg

1.13B

ADMA Biologics, Inc. (ADMA) Enterprise Value vs. Peers

How is ADMA’s Enterprise Value compared to its peers?

ADMA Biologics, Inc.’s Enterprise Value is less than ACADIA Pharmaceuticals Inc. (3.38B), less than Praxis Precision Medicines, Inc. (5.10B), less than Belite Bio, Inc (5.19B), less than Ligand Pharmaceuticals Incorporated (5.46B), less than Soleno Therapeutics, Inc. (2.63B), less than Mirum Pharmaceuticals, Inc. (4.99B), less than Dyne Therapeutics, Inc. (2.27B), less than Crinetics Pharmaceuticals, Inc. (3.57B), less than Telix Pharmaceuticals Limited (5.18B), less than Ultragenyx Pharmaceutical Inc. (3.42B),

Build a custom stock screener for ADMA Biologics, Inc. (ADMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ADMA Biologics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ADMA Biologics, Inc. (ADMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ADMA Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ADMA Biologics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for ADMA Biologics, Inc. (ADMA)?

What is the 3-year average Enterprise Value for ADMA Biologics, Inc. (ADMA)?

What is the 5-year average Enterprise Value for ADMA Biologics, Inc. (ADMA)?

How does the current Enterprise Value for ADMA Biologics, Inc. (ADMA) compare to its historical average?